当前位置:首页 - 行情中心 - 誉衡药业(002437) - 财务分析 - 现金流量表

誉衡药业

(002437)

  

流通市值:72.32亿  总市值:77.48亿
流通股本:20.96亿   总股本:22.46亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,211,784,742.07642,222,957.162,752,080,812.822,055,267,130.33
  收到的税费返还546,693.48---
  收到其他与经营活动有关的现金48,963,812.5615,317,161.65151,052,210.11128,985,193.4
  经营活动现金流入小计1,261,295,248.11657,540,118.812,903,133,022.932,184,252,323.73
  购买商品、接受劳务支付的现金168,639,415.7392,816,118.27416,461,760.19314,666,634.63
  支付给职工以及为职工支付的现金173,650,677.289,686,670.42369,025,953.98277,898,023.88
  支付的各项税费114,206,256.6656,066,320.35255,470,073.01193,692,775.03
  支付其他与经营活动有关的现金649,584,119.99312,496,515.621,451,239,432.641,097,492,387.57
  经营活动现金流出小计1,106,080,469.58551,065,624.662,492,197,219.821,883,749,821.11
  经营活动产生的现金流量净额155,214,778.53106,474,494.15410,935,803.11300,502,502.62
二、投资活动产生的现金流量:
  收回投资收到的现金692,999,000261,499,0006,000,0004,500,000
  取得投资收益收到的现金4,270,757.25462,086.0411,965,233.338,861,568.97
  处置固定资产、无形资产和其他长期资产收回的现金净额11,066,705.911,600,00018,731,619.4718,051,000
  投资活动现金流入小计708,336,463.16263,561,086.0436,696,852.831,412,568.97
  购建固定资产、无形资产和其他长期资产支付的现金13,318,605.546,511,825.9662,896,302.7633,754,967.07
  投资支付的现金1,010,000,000370,000,00030,000,000-
  取得子公司及其他营业单位支付的现金--2,664,502.382,509,802.38
  投资活动现金流出小计1,023,318,605.54376,511,825.9695,560,805.1436,264,769.45
  投资活动产生的现金流量净额-314,982,142.38-112,950,739.92-58,863,952.34-4,852,200.48
三、筹资活动产生的现金流量:
  吸收投资收到的现金--103,213,750103,213,750
  取得借款收到的现金70,000,00070,000,000115,000,000115,000,000
  筹资活动现金流入小计70,000,00070,000,000218,213,750218,213,750
  偿还债务支付的现金--789,860,000745,360,000
  分配股利、利润或偿付利息支付的现金6,038,757.7668,2509,358,200.279,105,144.71
  其中:子公司支付给少数股东的股利、利润5,621,674.43---
  支付其他与筹资活动有关的现金82,687,095.582,537,362.772,238,248.061,190,118.95
  筹资活动现金流出小计88,725,853.2682,605,612.77801,456,448.33755,655,263.66
  筹资活动产生的现金流量净额-18,725,853.26-12,605,612.77-583,242,698.33-537,441,513.66
四、汇率变动对现金及现金等价物的影响-266,848.95-90,972.85939,419.49-674,429.25
五、现金及现金等价物净增加额-178,760,066.06-19,172,831.39-230,231,428.07-242,465,640.77
  加:期初现金及现金等价物余额480,772,690.45480,780,934.88711,004,118.52711,004,118.52
  期末现金及现金等价物余额302,012,624.39461,608,103.49480,772,690.45468,538,477.75
补充资料:
  净利润137,424,012.98-242,540,034.93-
  资产减值准备910,744.9-3,448,945.61-
  固定资产和投资性房地产折旧27,841,117.61-60,791,185.49-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧27,841,117.61-60,791,185.49-
  无形资产摊销16,813,986.98-30,490,326.6-
  处置固定资产、无形资产和其他长期资产的损失-3,660,243.29--3,395,603.19-
  固定资产报废损失62,680.86-139,571.91-
  公允价值变动损失-8,559,844.12-13,979,364.47-
  财务费用824,015.84-8,688,785.12-
  投资损失-175,170.34--5,250,989.35-
  递延所得税1,019,439.73-5,711,818.91-
  其中:递延所得税资产减少1,281,690.78-4,545,039.89-
    递延所得税负债增加-262,251.05-1,166,779.02-
  存货的减少18,331,603.98--31,043,091.13-
  经营性应收项目的减少9,397,371.65-77,652,956.81-
  经营性应付项目的增加-52,777,434.73--17,054,511.32-
  其他7,083,644.12-23,558,155.89-
  现金的期末余额302,012,624.39-480,772,690.45-
  减:现金的期初余额480,772,690.45-711,004,118.52-
  现金及现金等价物的净增加额-178,760,066.06--230,231,428.07-
公告日期2025-08-272025-04-262025-04-262024-10-29
审计意见(境内)标准无保留意见
TOP↑